Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sallan, S. E.
Right arrow Articles by Frei, E 3.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sallan, S. E.
Right arrow Articles by Frei, E 3.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Intermittent combination chemotherapy with adriamycin for childhood acute lymphoblastic leukemia: clinical results

SE Sallan, BM Cammita, JR Cassady, DG Nathan and E Frei

One hundred thirty-seven children with previously untreated acute lymphoblastic leukemia were entered into a new program that included intermittent combination chemotherapy featuring Adriamycin. Remission induction was initially randomized to vincristine and prednisone with or without an anthracycline. All children received asparaginase consolidation and central nervous system prophylaxis with cranial irradiation and intrathecal methotrexate. There were no primary failures of CNS prophylaxis. Complications were primarily infectious. Clinical evidence of cardiotoxicity and leukoencephalopathy were not observed. The time to enter complete remission and the presence of an anterior mediastinal mass at diagnosis were found to be statistically significant adverse prognostic factors, whereas presenting age and white blood count were not. With a median follow-up of 26 mo, and using life plot analysis, 65% of the children have remianed in continuous complete remission.

Volume 51, Issue 3, pp. 425-433, 03/01/1978
Copyright © 1978 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 JCOHome page
E. V. Barry, L. M. Vrooman, S. E. Dahlberg, D. S. Neuberg, B. L. Asselin, U. H. Athale, L. A. Clavell, E. C. Larsen, A. Moghrabi, Y. Samson, et al.
Absence of Secondary Malignant Neoplasms in Children With High-Risk Acute Lymphoblastic Leukemia Treated With Dexrazoxane
J. Clin. Oncol., March 1, 2008; 26(7): 1106 - 1111.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. B. Nachman, H. N. Sather, M. G. Sensel, M. E. Trigg, J. M. Cherlow, J. N. Lukens, L. Wolff, F. M. Uckun, and P. S. Gaynon
Augmented Post-Induction Therapy for Children with High-Risk Acute Lymphoblastic Leukemia and a Slow Response to Initial Therapy
N. Engl. J. Med., June 4, 1998; 338(23): 1663 - 1671.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
R. J. MAYER
Acute Lymphoblastic Leukemia in Adults
Ann Intern Med, October 1, 1984; 101(4): 552 - 554.
[Abstract] [PDF]


click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1978 by American Society of Hematology         Online ISSN: 1528-0020